Genetic Technologies Limited (GENE) Ownership
GENE ownership summary
as of September 13, 2026- Institutions
- 1.9% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 4.8M
- Float
- 27.9M shares available to trade
- Short interest
- 0.56% 26K shares short
- Days to cover
- 15.67 short interest down 0.0% vs prior month
- Institutions 1.87%
- Other investors 98.13%
GENE top institutional holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Rhumbline Advisers | 0.07% | 2,650 | $5.3M | — | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 1, 0 holders added 0 shares and 0 cut 0.
GENE top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 0.01% | 502 | $1.0M | — | July 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
GENE shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns GENE
Institutional investors own 1.9% of Genetic Technologies's shares and insiders 0.00%. The largest holder is Rhumbline Advisers with 0.07% of the shares (2,650), as of March 31, 2026. Among the top 1 institutions, 0 added shares and 0 reduced their stake in the latest filings. Short interest is 0.56% of the float, or 15.67 days of average trading volume. The share count fell 40.9% since 2013.
Related: GENE key metrics. See the GENE stock overview for the latest quote and news.
GENE ownership FAQ
Who owns the most Genetic Technologies stock?
The largest shareholders of Genetic Technologies are Rhumbline Advisers (0.07%).
What percentage of Genetic Technologies is owned by institutions?
Institutions hold 1.9% of Genetic Technologies's shares outstanding; insiders hold 0.00%.
Which funds own Genetic Technologies?
The largest fund holders of Genetic Technologies are Fidelity Nasdaq Composite Index (0.01%).
What is Genetic Technologies's short interest?
26K shares of Genetic Technologies were sold short, 0.56% of the float; at the average daily volume it would take 15.67 days to cover.
How many shares of Genetic Technologies are outstanding?
Genetic Technologies has 4.8M shares outstanding, of which 27.9M are in the public float.